CLYM Climb Bio, Inc.
Healthcare$11.39+0.00%OpenMarket Cap: $776.6M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$20.00
Target (Median)
$20.00
Target Range
$17.00 - $25.00
Upside from current price: 75.6%
Rating Distribution
1 Strong Buy13 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-08 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-06 | BTIG | maintain | Buy | Buy |
| 2026-04-21 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-06 | Baird | maintain | Outperform | Outperform |
| 2026-03-06 | Wedbush | maintain | Outperform | Outperform |
| 2025-12-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-16 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.06 | $888.9K | 10 |
| Sun Dec 31 | $-1.43 | $0.00 | 11 |
| Mon Dec 31 | $-1.83 | $2.9M | 4 |
| Tue Dec 31 | $-1.92 | $51.0M | 4 |